Vio3 Apc3
Payments companies reported to CMS as associated with Vio3 Apc3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vio3 Apc3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vio3 Apc3
These are the largest totals companies reported as associated with Vio3 Apc3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dennis Yang | Orlando, FL | Gastroenterology (Internal Medicine) | $1,500.00 |
| Joo Hwang | Stanford, CA | Gastroenterology (Internal Medicine) | $240.58 |
| Kevin Yu | Houston, TX | Internal Medicine | $225.95 |
| Eric Yoon | Houston, TX | Critical Care Medicine (Internal Medicine) | $225.95 |
| Austin Thomas | Houston, TX | Internal Medicine | $181.95 |
| Faisal Ali | Brooklyn, NY | Internal Medicine | $160.73 |
| Sarma Challa | Baytown, TX | Cardiovascular Disease | $160.73 |
| Leka Gajula | Sugar Land, TX | Gastroenterology (Internal Medicine) | $160.73 |
| Azaan Ramani | Southlake, TX | Gastroenterology (Internal Medicine) | $160.73 |
| Prateek Harne | Edinburg, TX | Gastroenterology (Internal Medicine) | $160.73 |
Prescribed Vio3 Apc3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.